Preliminary Final Report FY2026

• Revenue increased by 12.7% to A$10.9 billion
• Underlying EBITDA grew 11%
• Net profit rose 18.4% to A$608 million
• Dividend increased by 1 cent to 63 cents

Sonic Healthcare Ltd has released its preliminary final report for the year ended 30 June 2026, reporting a 12.7% increase in revenue to A$10.9 billion. Underlying EBITDA grew by 11% and net profit increased by 18.4% to A$608 million. The company maintained a progressive dividend policy, increasing the full-year dividend by 1 cent to 63 cents, franked to 60%. Organic revenue growth was 5%, driven by strong performance in Europe and the UK, while EBITDA margin improved across most markets. The company achieved its full-year EBITDA guidance range and maintained tight cost control, reducing labor costs as a percentage of revenue by 30 basis points.

Revenue: A$10.9 billion, Underlying EBITDA: A$1.93 billion, Net profit: A$608 million

Sonic Healthcare Ltd anticipates continued growth in organic revenue and EBITDA, with a focus on driving operational efficiencies and capturing synergies from recent acquisitions. The company expects to maintain its progressive dividend policy.